Results 71 to 80 of about 44,732 (239)
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter +20 more
wiley +1 more source
Infection control in the brain and the eye
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester +2 more
wiley +1 more source
Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus [PDF]
PURPOSE: Longitudinal analysis of varicella-zoster virus DNA on the ocular surface of patients with herpes zoster ophthalmicus. METHODS: Clinical specimens were obtained from the bulbar conjunctival surface with a cotton-tipped swab at weekly intervals ...
Volker-Dieben, H.J. +10 more
core +1 more source
ABSTRACT Aim Countries with varicella immunisation programmes have seen major reductions in disease burden. While two‐dose schedules are now universally adopted, dosing ages vary, and some countries initially include catch‐up vaccination of older children to speed impact. This modelling study assessed three two‐dose schedules in the Swedish setting (1)
Gianpaolo Scalia Tomba +6 more
wiley +1 more source
We report a case of chronic hypersensitivity pneumonitis treated with pirfenidone in a 76-year-old woman who complained of acute-onset abdominal pain and rashes.
Akihiro Shiroshita +2 more
doaj +1 more source
Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson +2 more
wiley +1 more source
Control of herpes simplex virus type 1 latency in human trigeminal ganglia [PDF]
Herpes simplex virus type 1 (HSV-1) is a double-stranded DNA virus that infects humans and, after a primary lytic infection, establishes lifelong latency in the sensory neurons of the trigeminal ganglia (TG).
Held, Kathrin, Held, K.
core
ABSTRACT Aim To assess the cost‐effectiveness of including varicella vaccination in the Swedish national vaccination programme for children together with the added impact of catch‐up vaccination of susceptible older children. Methods An epidemiological transmission model was used to assess the cost‐effectiveness of a two‐dose national varicella ...
Frida Kasteng +5 more
wiley +1 more source
Varicella zoster virus-associated anterior uveitis in a seronegative adult without a history of chickenpox [PDF]
Izumi Mine, Sho Ishikawa, Masaru TakeuchiDepartment of Ophthalmology, National Defense Medical College, Tokorozawa City, Saitama, JapanAim: The aim of this report was to present a case of varicella zoster virus (VZV)-associated anterior uveitis, which ...
Ishikawa S, Takeuchi M, Mine I
core

